Skip to main content
OpenTrials

Clinical trial condition

Chronic Lymphocytic Leukemia

Explore clinical trials studying Chronic Lymphocytic Leukemia. Study availability and eligibility vary by location and protocol.

526 public trials 91 recruiting studies
Refine in advanced search Browse all conditions

Chronic Lymphocytic Leukemia trial results

Completed

Dose-Escalating and Safety Study of CP-461 in Patients With Chronic Lymphocytic Leukemia

NCT00036257

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Cancer Centers of Florida Orlando, Florida, United States
  • Albany Regional Cancer Center Albany, New York, United States
  • Mary Crowley Medical Research Center (US Oncology) Dallas, Texas, United States
  • Tyler Cancer Center Tyler, Texas, United States
View Trial Details
Completed

A Pilot Study of OSI-461 in Patients With Chronic Lymphocytic Leukemia (CLL)

NCT00073489

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Arizona Hematology & Oncology Associates Phoenix, Arizona, United States
  • Rocky Mountain Cancer Centers Aurora, Colorado, United States
  • Florida Oncology Associates Jacksonville, Florida, United States
  • Ocala Oncology Center Ocala, Florida, United States
View all 15 locations
View Trial Details
Completed

Kinetic Biomarker for Chronic Lymphocytic Leukemia Prognosis

NCT00481858

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • UCSD Medical Center San Diego, California, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • North Shore-Long Island Jewish Medical Center New Hyde Park, New York, United States
  • Ohio State University Columbus, Ohio, United States
View Trial Details
Completed

SPC2996 in Chronic Lymphocytic Leukaemia

NCT00285103

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Holden Comprehensive Cancer Center, Univ. of Iowa Iowa City, Iowa, United States
  • Rigshospitalet Copenhagen, Denmark
  • KAS Herlev Herlev, Denmark
  • Vejle Sygehus Vejle, Denmark
View Trial Details

Related conditions